These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 1974833)

  • 21. An ELISA-inhibition assay for antibody to human immunodeficiency virus core antigen (p24).
    Povolotsky J; Gold JW; Darminin P; Chein N; Baron P; Armstrong D
    J Virol Methods; 1990 Oct; 30(1):109-14. PubMed ID: 2128300
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acute HIV-1 infection: clinical and biological study of 12 patients.
    Sinicco A; Palestro G; Caramello P; Giacobbi D; Giuliani G; Paggi G; Sciandra M; Gioannini P
    J Acquir Immune Defic Syndr (1988); 1990; 3(3):260-5. PubMed ID: 1968096
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Absence of HIV infection in blood donors with indeterminate western blot tests for antibody to HIV-1.
    Jackson JB; MacDonald KL; Cadwell J; Sullivan C; Kline WE; Hanson M; Sannerud KJ; Stramer SL; Fildes NJ; Kwok SY
    N Engl J Med; 1990 Jan; 322(4):217-22. PubMed ID: 2403658
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Difficulties of investigation of antibodies against human immunodeficiency virus type 2 using ELISA].
    Soriano Vázquez V; Ribera Crusafont A; Tor Aquilera J; Muga Bustamante R
    Med Clin (Barc); 1988 Oct; 91(14):556-7. PubMed ID: 3216748
    [No Abstract]   [Full Text] [Related]  

  • 25. Immunoglobulin G antibody capture enzyme-linked immunosorbent assay: a versatile assay for detection of anti-human immunodeficiency virus type 1 and 2 antibodies in body fluids.
    Thongcharoen P; Wasi C; Louisirirotchanakul S; Parry J; Connell J; Mortimer P
    J Clin Microbiol; 1992 Dec; 30(12):3288-9. PubMed ID: 1452720
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Polyclonal B-cell activation reveals antibodies against human immunodeficiency virus type 1 (HIV-1) in HIV-1-seronegative individuals.
    Jehuda-Cohen T; Slade BA; Powell JD; Villinger F; De B; Folks TM; McClure HM; Sell KW; Ahmed-Ansari A
    Proc Natl Acad Sci U S A; 1990 May; 87(10):3972-6. PubMed ID: 2111024
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Indiscriminate determination of antibodies to human immunodeficiency virus].
    Salavert M; Tuset C; Vidal S; Navarro V
    Rev Clin Esp; 1991 Dec; 189(9):443-4. PubMed ID: 1792378
    [No Abstract]   [Full Text] [Related]  

  • 28. Association between anti-CD4 antibodies and a decline in CD4+ lymphocytes in human immunodeficiency virus type 1 seroconverters.
    Keay S; Wecksler W; Wasserman SS; Margolick J; Farzadegan H
    J Infect Dis; 1995 Feb; 171(2):312-9. PubMed ID: 7844366
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Early detection of human immunodeficiency virus type 1-specific B-lymphocyte-derived antibodies in a high-risk population.
    Odinsen O; Parker D; Radebe F; Guness M; Lewis DA
    Clin Vaccine Immunol; 2009 Jul; 16(7):1060-5. PubMed ID: 19474262
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Screening potential corneal donors for HIV-1 by polymerase chain reaction and a colorimetric microwell hybridization assay.
    Essary LR; Kinard SJ; Butcher A; Wang H; Laycock KA; Donegan E; McCreedy B; Connell S; Batchelor J; Harris J; Spadoro J; Pepose JS
    Am J Ophthalmol; 1996 Oct; 122(4):526-34. PubMed ID: 8862050
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Loss of human immunodeficiency virus type 1 (HIV-1) antibodies with evidence of viral infection in asymptomatic homosexual men: a report from the Multicenter AIDS Cohort Study.
    Dis Markers; 1989; 7(4):257-8. PubMed ID: 2684476
    [No Abstract]   [Full Text] [Related]  

  • 32. Human immunodeficiency viruses types 1 and 2 infection among replacement blood donors in Mumbai (Bombay).
    Kamat HA; Banker DD; Koppikar GV
    Indian J Med Sci; 2000 Feb; 54(2):43-51. PubMed ID: 11271723
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Testing of anti-HIV antibodies in saliva.
    Chassany O; Bergmann JF; Mazeron MC; Cervoni J; Grégoire V; Sanson-Le-Pors MJ; Caulin C
    AIDS; 1994 May; 8(5):713-4. PubMed ID: 8060558
    [No Abstract]   [Full Text] [Related]  

  • 34. Interpretation of western blots of specimens from children infected with human immunodeficiency virus type 1: implications for prognosis and diagnosis.
    Walter EB; McKinney RE; Lane BA; Weinhold KJ; Wilfert CM
    J Pediatr; 1990 Aug; 117(2 Pt 1):255-8. PubMed ID: 2380826
    [No Abstract]   [Full Text] [Related]  

  • 35. [Detection of HIV antibodies in saliva in a Parisian screening center].
    Chassany O; Mazeron MC; Cervoni J; Grégoire V; Sanson-Le-Pors MJ; Caulin C
    Presse Med; 1994 Apr; 23(14):674. PubMed ID: 8072972
    [No Abstract]   [Full Text] [Related]  

  • 36. Predicting progression to AIDS: combined usefulness of CD4 lymphocyte counts and p24 antigenemia.
    MacDonell KB; Chmiel JS; Poggensee L; Wu S; Phair JP
    Am J Med; 1990 Dec; 89(6):706-12. PubMed ID: 1979205
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reliable confirmation of antibodies to human immunodeficiency virus type 1 (HIV-1) with an enzyme-linked immunoassay using recombinant antigens derived from the HIV-1 gag, pol, and env genes.
    Ng VL; Chiang CS; Debouck C; McGrath MS; Grove TH; Mills J
    J Clin Microbiol; 1989 May; 27(5):977-82. PubMed ID: 2787334
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Continued monitoring for human immunodeficiency virus type 2 infections in California.
    Busch MP; Tobler L; Schable C; Petersen L
    Transfusion; 1992; 32(9):873. PubMed ID: 1471252
    [No Abstract]   [Full Text] [Related]  

  • 39. Performance characteristics of serologic tests for human immunodeficiency virus type 1 (HIV-1) antibody among Minnesota blood donors. Public health and clinical implications.
    MacDonald KL; Jackson JB; Bowman RJ; Polesky HF; Rhame FS; Balfour HH; Osterholm MT
    Ann Intern Med; 1989 Apr; 110(8):617-21. PubMed ID: 2648922
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Prevention of the risk of contamination of native blood products by the human immunodeficiency virus (HIV)].
    Rev Fr Transfus Hemobiol; 1989 Apr; 32(2):141-56. PubMed ID: 2757726
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.